We observed significantly higher levels of TREC in Tconv and Treg-cell populations after IL-2 administration (Fig. 6C) suggesting that IL-2 treatment indeed results in a higher thymic output of naïve Treg cells as observed in IL-2 treated human colorectal cancer patients. Here, IL2 is linked to colorectal cancer.